Network meta-analysis combines aggregate data (AgD) from multiple randomised controlled trials, assuming that any effect modifiers are balanced across populations. Individual patient data (IPD) meta-regression is the "gold standard" method to relax this assumption, however IPD are frequently only available in a subset of studies. Multilevel network meta-regression (ML-NMR) extends IPD meta-regression to incorporate AgD studies whilst avoiding aggregation bias, but currently requires the aggregate-level likelihood to have a known closed form. Notably, this prevents application to time-to-event outcomes.
We extend ML-NMR to individual-level likelihoods of any form, by integrating the individual-level likelihood function over the AgD covariate distributions to obtain the respective marginal likelihood contributions. We illustrate with two examples of time-to-event outcomes, showing the performance of ML-NMR in a simulated comparison with little loss of precision from a full IPD analysis, and demonstrating flexible modelling of baseline hazards using cubic M-splines with synthetic data on newly diagnosed multiple myeloma.
ML-NMR is a general method for synthesising individual and aggregate level data in networks of all sizes. Extension to general likelihoods, including for survival outcomes, greatly increases the applicability of the method. R and Stan code is provided, and the methods are implemented in the multinma R package.
Multilevel network meta-regression for multistate models: Population-adjusted joint synthesis of progression and survival from individual and aggregate data
University of California, San Francisco(旧金山加利福尼亚大学);UCSF Helen Diller Family Comprehensive Cancer Center(UCSF海伦·迪勒家族综合癌症中心);The Philip R. Lee Institute for Health Policy Studies(菲利普·李健康政策研究所);Precision AQ
Data-adaptive gene and pathway-based tests forrare-variant associations with survival outcomes
Medical College of Wisconsin(威斯康星医学院);German Cancer Research Center (DKFZ)(德国癌症研究中心);University of Leicester(莱斯特大学);Instituto de Investigación Sanitaria de Santiago de Compostela(圣地亚哥-德孔波斯特拉卫生研究所);Fundación Pública Galega de Medicina Xenómica(加利西亚公共基因组医学基金会);Biomedical Network on Rare Diseases (CIBERER)(罕见病生物医学网络);Icahn School of Medicine at Mount Sinai(西奈山伊坎医学院);Cross Cancer Institute, University of Alberta(阿尔伯塔大学交叉癌症研究所);University of Manchester(曼彻斯特大学);Ghent University / Ghent University Hospital(根特大学/根特大学医院)
Generating survival times using Cox proportional hazards models with cyclic time-varying covariates, with application to a multiple-dose monoclonal antibody clinical trial
University of Warwick(华威大学);Nanjing University(南京大学);London School of Economics and Political Science(伦敦政治经济学院);University of Cambridge(剑桥大学);Yale School of Public Health(耶鲁公共卫生学院)
Estimating Covariate-balanced Survival Curve in Distributed Data Environment using Data Collaboration Quasi-Experiment
University of Tsukuba(筑波大学);Tsukuba Institute for Advanced Research, University of Tsukuba(筑波大学先进研究学院);Institute of Systems and Information Engineering, University of Tsukuba(筑波大学系统信息工程学院);Center for Artificial Intelligence Research, Tsukuba Institute for Advanced Research, University of Tsukuba(筑波大学先进研究学院人工智能研究中心)
Bayesian random-effects meta-analysis of aggregate data on clinical events
University Medical Center Göttingen(哥廷根大学医学中心);University of Marburg(马尔堡大学);Merck KGaA(默克KGaA);DZHK (German Center for Cardiovascular Research)(德国心血管研究中心)
A new method for clustered survival data]{A new method for clustered survival data: Estimation of treatment effect heterogeneity and variable selection
Distributed learning optimisation of Cox models can leak patient data: Risks and solutions
Odense University Hospital(欧登塞大学医院);University of Southern Denmark(南丹麦大学);UNSW(新南威尔士大学);Ingham Institute for Applied Medical Research(英厄姆应用医学研究所);The University of Manchester(曼彻斯特大学);Manchester Academic Health Science Centre(曼彻斯特学术健康科学中心);The Christie NHS Foundation Trust(克里斯蒂国民保健服务基金会信托);University of Sydney(悉尼大学);Liverpool and Macarthur Cancer Therapy Centres(利物浦和麦克阿瑟癌症治疗中心)
Observing the unobserved confounding through its effects: toward randomized trial-like estimates from real-world survival data
Operations Research Center, Massachusetts Institute of Technology(麻省理工学院运营研究中心);Sloan School of Management, Massachusetts Institute of Technology(麻省理工学院斯隆管理学院);Department of Surgery, Memorial Sloan Kettering Cancer Center(纪念斯隆凯特琳癌症中心外科部);Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin(柏林夏里特医学院,柏林自由大学和洪堡大学联合成员)
Use of copula to model within-study association in bivariate meta-analysis of binomial data at the aggregate level a Bayesian approach and application to surrogate endpoint evaluation